Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis

Blood - Tập 110 - Trang 4096-4100 - 2007
Alberto Piperno1, Domenico Girelli2, Elizabeta Nemeth3, Paola Trombini1, Claudia Bozzini2, Erika Poggiali4, Yen Phung3, Tomas Ganz3, Clara Camaschella4
1Department of Clinical Medicine and Prevention, Milano-Bicocca University, San Gerardo Hospital, Monza, Italy
2Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
3Departments of Medicine and Pathology, David Geffen School of Medicine, University of California, Los Angeles (UCLA)
4Vita-Salute San Raffaele University and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy

Tóm tắt

Abstract

Inadequate hepcidin synthesis leads to iron overload in HFE-related hemochromatosis. We explored the regulation of hepcidin by iron in 88 hemochromatosis patients (61 C282Y/C282Y, 27 C282Y/H63D) and 23 healthy controls by analyzing urinary hepcidin before and 24 hours after a 65-mg oral iron dose. Thirty-four patients were studied at diagnosis and had iron overload, and 54 patients were iron depleted. At diagnosis, hepcidin values in C282Y homozygotes were similar to controls, whereas values in C282Y/H63D heterozygotes were higher (P = .02). However, the hepcidin/ferritin ratio was decreased in both homozygotes (P < .001) and heterozygotes (P = .017), confirming the inadequate hepcidin production for the iron load with both genotypes. In iron-depleted patients of both genotypes studied at a time remote from phlebotomy, basal hepcidin was still lower than in controls (P < .001 for C282Y/C282Y and P = .002 for heterozygotes). After an iron challenge, mean urinary hepcidin excretion increased in controls (P = .001) but not patients, irrespective of genotype and iron status. Significant hepcidin increase ( ≥ 10 ng/mg creatinine) was observed in 74% of controls, 15% of homozygotes, and 32% of heterozygotes. The hepcidin response to oral iron is blunted in HFE-related hemochromatosis and not improved after iron depletion. The findings support the involvement of HFE in iron sensing and subsequent regulation of hepcidin.


Tài liệu tham khảo

Camaschella, 2005, Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders., Blood, 106, 3710, 10.1182/blood-2005-05-1857 Pietrangelo, 2004, Hereditary hemochromatosis—a new look at an old disease., N Engl J Med, 350, 2383, 10.1056/NEJMra031573 Beutler, 2002, Penetrance of 845G–> A (C282Y) HFE hereditary haemochromatosis mutation in the USA., Lancet, 359, 211, 10.1016/S0140-6736(02)07447-0 Olynyk, 1999, A population-based study of the clinical expression of the hemochromatosis gene., N Engl J Med, 341, 718, 10.1056/NEJM199909023411002 Asberg, 2001, Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65 238 persons., Scand J Gastroenterol, 36, 1108, 10.1080/003655201750422747 Olynyk, 2004, Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study., Mayo Clin Proc, 79, 309, 10.4065/79.3.309 Andersen, 2004, Hemochromatosis mutations in the general population: iron overload progression rate., Blood, 103, 2914, 10.1182/blood-2003-10-3564 Ganz, 2005, Hepcidin–a regulator of intestinal iron absorption and iron recycling by macrophages., Best Pract Res Clin Haematol, 18, 171, 10.1016/j.beha.2004.08.020 Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization., Science, 306, 2090, 10.1126/science.1104742 Bridle, 2003, Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis., Lancet, 361, 669, 10.1016/S0140-6736(03)12602-5 Gehrke, 2003, Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron., Blood, 102, 371, 10.1182/blood-2002-11-3610 Gleeson, 2007, Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis., Blood Cells Mol Dis, 38, 37, 10.1016/j.bcmd.2006.09.008 Ahmad, 2002, Decreased liver hepcidin expression in the HFE knockout mouse., Blood Cells Mol Dis, 29, 361, 10.1006/bcmd.2002.0575 Muckenthaler, 2003, Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis., Nat Genet, 34, 102, 10.1038/ng1152 Nemeth, 2004, IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin., J Clin Invest, 113, 1271, 10.1172/JCI200420945 Vokurka, 2006, Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis., Physiol Res, 55, 667, 10.33549/physiolres.930841 Pak, 2006, Suppression of hepcidin during anemia requires erythropoietic activity., Blood, 108, 3730, 10.1182/blood-2006-06-028787 Nicolas, 2002, The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation., J Clin Invest, 110, 1037, 10.1172/JCI0215686 Piperno, 1996, The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients., Hepatology, 24, 43, 10.1002/hep.510240109 Nemeth, 2003, Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein., Blood, 101, 2461, 10.1182/blood-2002-10-3235 Papanikolaou, 2005, Hepcidin in iron overload disorders., Blood, 105, 4103, 10.1182/blood-2004-12-4844 Lin, 2007, Iron-transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4., Blood, 110, 2182, 10.1182/blood-2007-04-087593 2000, J Hepatol, 496